DFW Capital Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

DFW Capital Partners’ most common sectors for investment areinformation technology (20%) and life science (20%) . The Firm’s most common investment types include growth capital (43%) and buyout (lbo, mbo, mbi) (23%). In total, DFW Capital Partners has invested in 17 US states. Its largest (disclosed) acquisition occurred in 1999 when it acquired Sheridan Healthcare for $155M.

In the last 3 years, DFW Capital Partners has exited 1 company. The Firm’s most common exit type is trade sale (46%). DFW Capital Partners’ largest (disclosed) exit occurred in 2014 when it sold Vidara Therapeutics for $660M.

Join Mergr to view DFW Capital Partners’ full profile and discover more middle-market private equity firm investors just like it.

M&A Summary

  • M&A Total Activity59
    • M&A Buy Activity35
    • M&A Sell Activity24
  • Total Sectors Invested 16
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 23

DFW Capital Partners

300 Frank W. Burr Blvd., Glenpointe Centre East, 5th Floor,
Teaneck, New Jersey 07666
United States
(201) 836-6000
www.dfwcapital.com
info@dfwcapital.com

DFW Capital Partners is a private equity firm that invests in high-growth middle-market service companies generating revenues up to $200 million. Specific service areas of interest include business services, industrial services, and healthcare services. Prospective transactions include growth capital financing, acquisition financing, management buyouts, and recapitalization. DFW will not invest in start-ups, real estate, or pure R&D companies. DFW Capital Partners was formed in 1983 and is based in Teaneck, New Jersey.


Investment Criteria

Sectors of Interest: Business Services, Environmental, Healthcare Services, Information Technology, Insurance, Internet Software and Services, Life Science, Medical Products, Software

Target Transaction Types: Buyout (LBO, MBO, MBI), Divestiture, Growth Capital, Recapitalization

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue - 200
Target EBITDA - 20
Investment Size - -
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.8/yr) # 31 4 - - - - 35
vol $155M $155M
Sell (0.6/yr) # 21 2 1 - - - 24
vol $1.4B $1.4B
  59

Most Recent M&A

Company Date Value Type
CDHA Holdings, LLC 2022-01-12 - Add-on Acquisition
West Chester, Pennsylvania · www.childrensdentalhealth.com
Herspiegel Consulting LLC 2021-12-14 - Growth Capital
Yardley, Pennsylvania · www.herspiegelconsulting.com
ReSource Pro 2021-12-01 - Recapitalization
New York, New York · www.resourcepro.com
American Track 2021-11-30 - Secondary Buyout
Fort Worth, Texas · www.americantrack.com
Industrial Security Integrators, LLC 2021-10-01 - Stake Purchase
Herndon, Virginia · www.dodsecurity.com
RQM+ Corp. 2021-08-16 - Secondary Buyout
Monroeville, Pennsylvania · www.rqmplus.com
Vantage Insurance Partners, Inc. 2021-01-15 - Stake Purchase
New York, New York · www.vantageptr.com
EPIC IO 2020-05-07 - Stake Purchase
Fort Mill, South Carolina · www.epicio.com
WorldCare Clinical LLC 2020-01-06 - Growth Capital
Boston, Massachusetts · www.wcclinical.com
RQM+ Corp. 2019-10-11 - Growth Capital
Monroeville, Pennsylvania · www.rqmplus.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Saol Therapeutics 2017-01-02 Aptevo Therapeutics, Inc. - Hyperimmune Commercial Products 2017-08-31 1
Roswell, Georgia · www.saolrx.com Seattle, Washington
Envocore 2017-06-30 LRI Energy Solutions LLC 2017-06-30 1
Gambrills, Maryland · www.envocore.com Gambrills, Maryland · www.lrienergysolutions.com

M&A by Sector

Sector Current # Value All-time # Value
Information Technology 5 (36%) - 7 (20%) -
Life Science 4 (29%) - 7 (20%) -
Healthcare Services - - 5 (14%) 155M (100%)
Business Services 1 (7%) - 4 (11%) -
Construction 1 (7%) - 1 (3%) -
Consumer Services - - 1 (3%) -
Defense - - 1 (3%) -
Electrical Equipment 1 (7%) - 1 (3%) -
Electronics - - 1 (3%) -
Engineering - - 1 (3%) -
Environmental 1 (7%) - 1 (3%) -
Insurance 1 (7%) - 1 (3%) -
Medical Products - - 1 (3%) -
Renewable Energy - - 1 (3%) -
Safety/Security - - 1 (3%) -
Software - - 1 (3%) -
Total 14 - 35 $155M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 14 (100%) - 35 (100%) 155M (100%)
  Pennsylvania 1 (7%) - 6 (17%) -
  Georgia 2 (14%) - 4 (11%) -
  Virginia 2 (14%) - 3 (9%) -
  New York 1 (7%) - 3 (9%) -
  New Jersey - - 3 (9%) -
  Texas 2 (14%) - 2 (6%) -
  Maryland 1 (7%) - 2 (6%) -
  California 1 (7%) - 2 (6%) -
  Florida - - 2 (6%) 155M (100%)
  South Carolina 1 (7%) - 1 (3%) -
  Ohio 1 (7%) - 1 (3%) -
  North Carolina 1 (7%) - 1 (3%) -
  Massachusetts 1 (7%) - 1 (3%) -
  Vermont - - 1 (3%) -
  Tennessee - - 1 (3%) -
  New Hampshire - - 1 (3%) -
  Michigan - - 1 (3%) -
Total 14 - 35 $155M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 7 (50%) - 15 (43%) -
Buyout (LBO, MBO, MBI) 2 (14%) - 8 (23%) -
Recapitalization 1 (7%) - 6 (17%) -
Stake Purchase 3 (21%) - 3 (9%) -
Going Private - - 1 (3%) 155M (100%)
Consolidation - - 1 (3%) -
Secondary Buyout 1 (7%) - 1 (3%) -
Total 14 - 35 $155M

Exits by Deal Type

Type Total # Value
Secondary Sale 9 (38%) 161M (11%)
Trade Sale - Public Company 8 (33%) 1.3B (89%)
Trade Sale 5 (21%) -
Merger 1 (4%) -
Recapitalization 1 (4%) -
Total 24 $1.4B

Deal Values

buy # Total
$100M to $1B 1 $155M
TOTAL $155M
Largest Sheridan Healthcare, Inc.
$155M (1999-05-01)
sell # Total
$100M to $1B 3 $1.2B
< $100M 4 $262M
TOTAL $1.4B
Largest Vidara Therapeutics, Inc.
$660M (2014-03-19)

M&A Connections

Deals
Acquired from
Investor(s)
9%
3 (9%)
Exited to
Investor(s)
42%
10 (42%)
Strategic(s)
46%
11 (46%)

Investor Summary

Investor Type

Private Equity Firm

Size

Middle-Market

PE Assets

600M USD

Established

1983

Specialist/Generalist

Generalist

Leadership

Donald DeMuth

Co-founder & Partner

Keith Pennell

Managing Partner

Cheri Lieberman

CFO

Brett Prager

Partner

Brian Tilley

Partner

 Subscribe to unlock this and 193,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 184K M&A Transactions
  • 189K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 72K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal